Cargando…
Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen
OBJECTIVES: The analysis of secretin-stimulated pancreatic fluid is being evaluated as an approach to improve the early detection of pancreatic cancer and pancreatic precursor neoplasms. The method of pancreatic fluid sampling may have a significant impact on tumor marker measurements. The aim of th...
Autores principales: | Sadakari, Yoshihiko, Kanda, Mitsuro, Maitani, Kosuke, Borges, Michael, Canto, Marcia I, Goggins, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543403/ https://www.ncbi.nlm.nih.gov/pubmed/25393586 http://dx.doi.org/10.1038/ctg.2014.14 |
Ejemplares similares
-
GNAS and KRAS Mutations are Common in Intraductal Papillary Neoplasms of the Bile Duct
por: Sasaki, Motoko, et al.
Publicado: (2013) -
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
por: Yu, Jun, et al.
Publicado: (2017) -
Neostigmine(®) Improves Pancreatic Duct Visualization in Magnetic Resonance Cholangiopancreatography and Could Be a Cheap Alternative for Secretin
por: Toledo, Paulina F., et al.
Publicado: (2022) -
Secretin-stimulated MR cholangiopancreatography: spectrum of findings in pancreatic diseases
por: Boraschi, Piero, et al.
Publicado: (2016) -
Overexpression of ankyrin1 promotes pancreatic cancer cell growth
por: Omura, Noriyuki, et al.
Publicado: (2016)